F. Vanaclocha

4.2k citations
130 papers · 2.7k · 1 hit paper · h-index 26

Impact in

  • Dermatology top 0.2%
    • Dermatology and Skin Diseases
    • Cutaneous lymphoproliferative disorders research
  • Immunology top 1%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Dermatology and Skin Diseases 16
    • Cutaneous lymphoproliferative disorders research 15
    • Cancer and Skin Lesions 7
    • Psoriasis: Treatment and Pathogenesis 43

F. Vanaclocha

122 papers receiving 2.6k citations

F. Vanaclocha's Hit Papers

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial 2015 · 429 citations
4290+3+7Years since publication100200300400

Peers

F. Vanaclocha
Comparison fields: 5 of 103
  • Dermatology 1.3k
  • Immunology 1.7k
  • Rheumatology 458
  • Immunology and Allergy 175
  • Pathology and Forensic Medicine 460
Replace I. García‐Doval with:
I. García‐Doval Spain
Siegfried Segaert Belgium
Stefano Piaserico Italy
Jeffrey Crowley United States
Bernard S. Goffe United States
E. Puzenat France
Laurence Le Cleach France
Pierre‐Dominique Ghislain Belgium
Enrique Rivas Mexico
Marcus Schmitt‐Egenolf Sweden
F. Vanaclocha relative to I. García‐Doval Spain I. García‐Doval's profile →
Citations per field
00.5×1.6×
I. García‐Doval · 1×
Citations per year

Countries citing papers authored by F. Vanaclocha

Since Specialization
Citations

This map shows the geographic impact of F. Vanaclocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Vanaclocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Vanaclocha more than expected).

Fields of papers citing papers by F. Vanaclocha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Vanaclocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Vanaclocha. The network helps show where F. Vanaclocha may publish in the future.

Co-authors

The 25 scholars most cited alongside F. Vanaclocha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Vanaclocha Line = papers co-authored together F. Vanaclocha links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
Hit paper breakdown →
2015429
2 2016231
3 2003151
4 2004121
5 2001100
6 200979
7 200971
8 201664
9 200062
10 201359
11 201054
12 200854
13 201442
14 200239
15 201538
16 201237
17 201336
18 201335
19 201034
20 200932

About F. Vanaclocha

F. Vanaclocha is a scholar working on Dermatology, Immunology, Epidemiology, Rheumatology and Pathology and Forensic Medicine, having authored 130 papers that have together received 2.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (43 papers), Dermatology and Skin Diseases (16 papers), Cutaneous lymphoproliferative disorders research (15 papers), Autoimmune Bullous Skin Diseases (14 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Spondyloarthritis Studies and Treatments (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Cancer and Skin Lesions (7 papers). The work is most often cited by research in Dermatology (1.3k citations), Immunology (1.7k citations), Rheumatology (458 citations), Immunology and Allergy (175 citations) and Pathology and Forensic Medicine (460 citations). F. Vanaclocha has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include E. Daudén, Kristian Reich, Andrew Blauvelt, Diamant Thaçi, M. Milutinovic, Michael Ziv, Külli Kingo, Andreas Pinter, Sophie Hugot and Tsen‐Fang Tsai. Their work appears in journals such as Actas Dermo-Sifiliográficas, Journal of the European Academy of Dermatology and Venereology, Journal of the American Academy of Dermatology, Journal of Crohn s and Colitis and Journal of Dermatological Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact